Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,2012,220 of 20,252 grants

Active NON-SBIR/STTR RPGS
Genomic and environmental drivers of HCC in Non-Hispanic Blacks: Nature and nurture
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2023 – 2027

Genomicand environmental drivers of HCC in Non-Hispanic Blacks: Nature and nurture: Non-Hispanic Black Americans (Blacks) develop hepatocellular carcinoma (HCC) at about twice the...

$3.6M
USD
Active NON-SBIR/STTR RPGS
TET2-mediated epitranscriptomic regulation in leukemia microenvironment
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2023 – 2028

PROJECT SUMMARY: Background: Acute myeloid leukemia (AML) is one of the most aggressive types of hematopoietic malignancies with various genetic alterations. Ten-Eleven Translocati...

$6.5M
USD
Active NON-SBIR/STTR RPGS
Genomic and environmental drivers of HCC in Non-Hispanic Blacks: Nature and nurture
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2023 – 2027

Genomicand environmental drivers of HCC in Non-Hispanic Blacks: Nature and nurture: Non-Hispanic Black Americans (Blacks) develop hepatocellular carcinoma (HCC) at about twice the...

$3.26M
USD
Active SBIR-STTR RPGS
Extended half-life GlyTR1 combined with checkpoint blockade for Cancer Immunotherapy
NATIONAL CANCER INSTITUTE Glytr Therapeutics, Inc United States 2023 – 2026

Abstract Treatment of non-resectable recurrent/metastatic solid cancers is currently palliative only and there is an urgent unmet need for novel mechanisms of action and additional...

$9.09M
USD
Completed RESEARCH CENTERS
Impact of race and ethnicity on outcomes in patients with hormone receptor-positive breast cancer treated with CDK4/6 inhibitors
NATIONAL CANCER INSTITUTE Texas Southern University United States 2023 – 2025

Breast cancer (BC) is the most common cancer in women worldwide and is the second leading cause of cancer death in women. However, the advances in outcomes of BC patients have been...

Active SBIR-STTR RPGS
Preclinical and IND enabling studies for treatment of advanced lung cancer and other cancers metastatic to lung by pulmonary delivery of engineered Influenza A Virus (eIAV)
NATIONAL CANCER INSTITUTE Accurius Therapeutics, Inc United States 2023 – 2026

PROJECT SUMMARY / ABSTRACT There are more than 230,000 new cases of lung cancer and over 130,000 deaths due to lung cancer each year in the U.S. Approximately 120,000 people each y...

$10M
USD
Active NON-SBIR/STTR RPGS
New Epidemiologic Methods for Reducing Measurement Error and Misclassification Bias in Cancer Epidemiology
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2027

Project Summary/Abstract Uncertainty in exposure and outcome measurements poses substantial challenges to the identification and quantification of the causes of cancer. For example...

$7.5M
USD
Active TRAINING, INDIVIDUAL
Chromunities Drive Transcriptional Reprogramming in Humoral Immunity and B-cell Lymphomas
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT Diffuse large B-cell lymphomas (DLBCL) arise from B-cells transiting different stages of the germinal center (GC) reaction. It has become clear that these...

$476.9K
USD
Active NON-SBIR/STTR RPGS
Advancing breast cancer risk prediction in national cohorts: the role of mammogram-based deep learning
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2026

To date, significant efforts devoted to developing breast cancer risk prediction models that produce modest discriminatory accuracy in the range of 59-68% and underperform in Black...

$6.72M
USD
Active NON-SBIR/STTR RPGS
Engineering Exosome for Pancreatic Cancer Targeting Therapies
NATIONAL CANCER INSTITUTE University of Toledo Health Sci Campus United States 2023 – 2028

Pancreatic Ductal Adenocarcinoma (PDAC) is one of the deadliest cancers and ranks fourth in cancer- related deaths in the United States. Therapies for pancreatic cancer are largely...

$4.87M
USD
Active NON-SBIR/STTR RPGS
Adaptation and implementation of a web-based Family centered Adolescent Sperm banking decision Tool for adolescent males with cancer
NATIONAL CANCER INSTITUTE Research Inst Nationwide Children'S Hosp United States 2023 – 2028

PROJECT SUMMARY Advances in childhood cancer therapies have resulted in >80% five-year survival rates.1 With nearly 500,000 childhood cancer survivors in the U.S., there is a gr...

$3.67M
USD
Active NON-SBIR/STTR RPGS
Incorporating residential histories into assessment of cancer risk in a predominantly low-income and racially diverse population
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2023 – 2027

PROJECT SUMMARY/ABSTRACTThere is growing recognition that area-level biological and physical exposures associated with residential location across the life-course must be considere...

$6.02M
USD
Active NON-SBIR/STTR RPGS
Developing and Testing a Culturally Tailored Mobile Health and Social MediaPhysical Activity Intervention Among Adolescent and Young Adult ChildhoodCancer Survivors
NATIONAL CANCER INSTITUTE Seattle Children'S Hospital United States 2023 – 2026

ABSTRACT Latinx childhood cancer survivors have an increased risk of cardiometabolic dysfunction. While physical activity (PA) is associated with lower risk of cancer recurrence, c...

$4.31M
USD
Active NON-SBIR/STTR RPGS
Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Androgen indifferent prostate cancers account for a large proportion of the disease lethality and have limited therapy options, partly due to the lack of i...

$6.05M
USD
Active NON-SBIR/STTR RPGS
A novel molecularly targeted theranostic approach via the alphavbeta6 integrin for the detection and treatment of metastatic cancers
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT We propose to evaluate a novel αvβ6 integrin molecularly targeted theranostic approach for the detection and treatment of metastatic cancers. The αvβ6 inte...

$6.35M
USD
Active RESEARCH CENTERS
Racial and social contextual factors in relation to epigenome and bladder cancer outcome.
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2023 – 2027

CURED PILOT Project 2 Summary This proposal entails strengthening the efforts between Dan L Duncan Comprehensive Cancer Center (DLDCCC) at Baylor College of Medicine (BCM) and Texa...

Active RESEARCH CENTERS
BCM-TSU CURED Cancer Research Education Program (C-REP)
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2023 – 2027

CURED C-REP Summary/Abstract The Collaborative Cancer Research Education Program (C-REP) of the Baylor College of Medicine (BCM)/ Dan L Duncan Comprehensive Cancer Center (DLDCCC)...

Completed SBIR-STTR RPGS
Extended half-life GlyTR1 combined with checkpoint blockade for Cancer Immunotherapy
NATIONAL CANCER INSTITUTE Glytr Therapeutics, Inc United States 2023 – 2024

Abstract Treatment of non-resectable recurrent/metastatic solid cancers is currently palliative only and there is an urgent unmet need for novel mechanisms of action and additional...

$4M
USD
Active NON-SBIR/STTR RPGS
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Melanoma (MEL) is a model malignancy for studying the mechanisms of cancer immunotherapy. Antibodies that block negative regulators of T cell function, ter...

$5.07M
USD
Active NON-SBIR/STTR RPGS
Targeted radiation and immunocytokine therapy for CEA positive malignancies
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2023 – 2028

SUMMARY/ABSTRACT Image guided radiotherapy (IGRT) or systemically administered radionuclide therapy are attractive approaches that can perturb the tumor microenvironment (TME) so t...

$6.42M
USD